Supplementary Figure 2 from Api6/AIM/Spα/CD5L Overexpression in Alveolar Type II Epithelial Cells Induces Spontaneous Lung Adenocarcinoma

Yuan Li,Peng Qu,Lingyan Wu,Beilin Li,Hong Du,Cong Yan

DOI: https://doi.org/10.1158/0008-5472.22388760

2023-01-01

Abstract:Supplementary Figure 2 from Api6/AIM/Spα/CD5L Overexpression in Alveolar Type II Epithelial Cells Induces Spontaneous Lung Adenocarcinoma

What problem does this paper attempt to address?

Data from Api6/AIM/Spα/CD5L Overexpression in Alveolar Type II Epithelial Cells Induces Spontaneous Lung Adenocarcinoma

Yuan Li,Peng Qu,Lingyan Wu,Beilin Li,Hong Du,Cong Yan

DOI: https://doi.org/10.1158/0008-5472.c.6502362.v1

2023-01-01

Abstract:AbstractChronic inflammation is an important contributor to the development of lung cancers, one of the most common malignancies worldwide, but the underlying molecular mechanisms of inflammation that specifically cue cancer risk remain poorly understood. Apoptosis inhibitor 6 (Api6, also known as AIM, Sp-α, and CD5L) is a downstream target gene of neutral lipids and peroxisome proliferator–activated receptor gamma in lung alveolar type II (AT II) epithelial cells. An association among increased expression of Api6 in certain settings of pathogenic lung inflammation in mice prompted us to hypothesize a possible role in cancer. Here, we report that Api6 promotes malignant transformation by limiting lung epithelial cell apoptosis and promoting immune escape. The specific function of Api6 in AT II cells was determined by using a doxycycline-inducible Api6 mouse model. Api6 overexpression inhibited apoptosis and activated oncogenic signaling in AT II lung epithelial cells, inducing emphysema and adenocarcinoma. In addition, Api6 overexpression in AT II cells increased the concentrations of proinflammatory cytokines/chemokines in bronchoalveolar lavage fluid and serum, promoting expansion of myeloid-derived suppressor cells (MDSC) in lung and blood but not in bone marrow or spleen. Lung MDSCs suppressed T-cell proliferation and activity in vitro and reduced levels of T cells in vivo following doxycycline treatment to activate Api6. Together, our findings establish that Api6 promotes lung tumorigenesis by blocking a mechanism of epithelial apoptosis that would normally support immunosurveillance. Cancer Res; 71(16); 5488–99. ©2011 AACR.
Alveolar Type Ii Cells Possess The Capability Of Initiating Lung Tumor Development

Chuwen Lin,Hai Song,Cecilia Huang,Erica Yao,Rhodora Gacayan,Shan-Mei Xu,Pao-Tien Chuang

DOI: https://doi.org/10.1371/journal.pone.0053817

IF: 3.7

2012-01-01

PLoS ONE

Abstract:Identifying cells of tumor origin is a fundamental question in tumor biology. Answers to this central question will not only advance our understanding of tumor initiation and progression but also have important therapeutic implications. In this study, we aimed to uncover the cells of origin of lung adenocarcinoma, a major subtype of non-small cell lung cancer. To this end, we developed new mouse models of lung adenocarcinoma that enabled selective manipulation of gene activity in surfactant associated protein C (SPC)-expressing cells, including alveolar type II cells and bronchioalveolar stem cells (BASCs) that reside at the bronchioalveolar duct junction (BADJ). Our findings showed that activation of oncogenic Kras alone or in combination with the removal of the tumor suppressor p53 in SPC+ cells resulted in development of alveolar tumors. Similarly, sustained EGF signaling in SPC+ cells led to alveolar tumors. By contrast, BASCs failed to proliferate or produce tumors under these conditions. Importantly, in a mouse strain in which Kras/p53 activity was selectively altered in type II cells but not BASCs, alveolar tumors developed while BADJs retained normal architecture. These results confirm and extend previous findings and support a model in which lung adenocarcinoma can initiate in alveolar type II cells. Our results establish the foundation for elucidating the molecular mechanisms by which lung cancer initiates and progresses in a specific lung cell type. Citation: Lin C, Song H, Huang C, Yao E, Gacayan R, et al. (2012) Alveolar Type II Cells Possess the Capability of Initiating Lung Tumor Development. PLoS ONE 7(12): e53817. doi:10.1371/journal.pone.0053817
Supplementary Tables 1-3 from Activation of the Signal Transducers and Activators of the Transcription 3 Pathway in Alveolar Epithelial Cells Induces Inflammation and Adenocarcinomas in Mouse Lung

Yuan Li,Hong Du,Yulin Qin,Jennifer Roberts,Oscar W. Cummings,Cong Yan

DOI: https://doi.org/10.1158/0008-5472.22367861

2023-01-01

Abstract:Supplementary Tables 1-3 from Activation of the Signal Transducers and Activators of the Transcription 3 Pathway in Alveolar Epithelial Cells Induces Inflammation and Adenocarcinomas in Mouse Lung
Supplementary Figure 1 from Stomatin-like Protein 2 is Overexpressed in Cancer and Involved in Regulating Cell Growth and Cell Adhesion in Human Esophageal Squamous Cell Carcinoma

Liyong Zhang,Fang Ding,Weijun Cao,Zhongmin Liu,Wei Liu,Zhengping Yu,Yu Wu,Wendong Li,Yanda Li,Zhihua Liu

DOI: https://doi.org/10.1158/1078-0432.22441746.v1

2023-01-01

Abstract:Supplementary Figure 1 from Stomatin-like Protein 2 Is Overexpressed in Cancer and Involved in Regulating Cell Growth and Cell Adhesion in Human Esophageal Squamous Cell Carcinoma
Supplementary Data from Identification of Active Bronchioalveolar Stem Cells as the Cell of Origin in Lung Adenocarcinoma

Huijing Yin,Bo Jing,Dongliang Xu,Wenzheng Guo,Beibei Sun,Jie Zhang,Yueling Liao,Hongyong Song,Tong Wang,Shuli Liu,Yanbin Kuang,Min Hu,Kaimi Li,Siwei Zhang,Hongjia Zhang,Jianhua Xu,Xue Li,Jing Du,Yadi Wu,Yingli Wu,Qi Wang,Feng Yao,Yueh Eugene Chin,Binhua P. Zhou,Jiong Deng

DOI: https://doi.org/10.1158/0008-5472.22431153

2023-01-01

Abstract:Supplementary Data from Identification of Active Bronchioalveolar Stem Cells as the Cell of Origin in Lung Adenocarcinoma
Supplementary Figure S5 from the N6-methyladenosine Epitranscriptomic Landscape of Lung Adenocarcinoma

Shiyan Wang,Yong Zeng,Lin Zhu,Min Zhang,Lei Zhou,Weixiong Yang,Weishan Luo,Lina Wang,Yanming Liu,Helen Zhu,Xin Xu,Peiran Su,Xinyue Zhang,Musaddeque Ahmed,Wei Chen,Moliang Chen,Sujun Chen,Mykhaylo Slobodyanyuk,Zhongpeng Xie,Jiansheng Guan,Wen Zhang,Aafaque Ahmad Khan,Shingo Sakashita,Ni Liu,Nhu-An Pham,Paul C. Boutros,Zunfu Ke,Michael F. Moran,Zongwei Cai,Chao Cheng,Jun Yu,Ming S. Tsao,Housheng H. He

DOI: https://doi.org/10.1158/2159-8290.27434168

2024-01-01

Abstract:Live cell imaging of EML4-overexpressing H358 cells in wound healing assay.
Supplementary Figure S1 from Molecular Portraits of Epithelial, Mesenchymal, and Hybrid States in Lung Adenocarcinoma and Their Relevance to Survival

Mark J. Schliekelman,Ayumu Taguchi,Jun Zhu,Xudong Dai,Jaime Rodriguez,Muge Celiktas,Qing Zhang,Alice Chin,Chee-Hong Wong,Hong Wang,Lisa McFerrin,Suhaida A. Selamat,Chenchen Yang,Evan M. Kroh,Kavita S. Garg,Carmen Behrens,Adi F. Gazdar,Ite A. Laird-Offringa,Muneesh Tewari,Ignacio I. Wistuba,Jean P. Thiery,Samir M. Hanash

DOI: https://doi.org/10.1158/0008-5472.22406754

2023-01-01

Abstract:Supplementary Figure S1. Background information for lung adenocarcinoma cell lines.
Supplementary Text from CXCR2 Expression in Tumor Cells Is a Poor Prognostic Factor and Promotes Invasion and Metastasis in Lung Adenocarcinoma

Pierre Saintigny,Erminia Massarelli,Steven Lin,Young-Ho Ahn,Yulong Chen,Sangeeta Goswami,Baruch Erez,Michael S. O'Reilly,Diane Liu,J. Jack Lee,Li Zhang,Yuan Ping,Carmen Behrens,Luisa M. Solis Soto,John V. Heymach,Edward S. Kim,Roy S. Herbst,Scott M. Lippman,Ignacio I. Wistuba,Waun Ki Hong,Jonathan M. Kurie,Ja Seok Koo

DOI: https://doi.org/10.1158/0008-5472.22394118.v1

2023-01-01

Abstract:PDF file - 110K, Supplemental Material and Methods, Supplementary Tables 1 and 2: Univariate Cox model assessing the effect of covariates on overall survival, Supplementary Table 3: Final multicovariate Cox models assessing the effect of covariates on recurrence-free survival in the whole population (N=262), Supplemental Figure Legends
Supplementary Video S2 from the N6-methyladenosine Epitranscriptomic Landscape of Lung Adenocarcinoma

Shiyan Wang,Yong Zeng,Lin Zhu,Min Zhang,Lei Zhou,Weixiong Yang,Weishan Luo,Lina Wang,Yanming Liu,Helen Zhu,Xin Xu,Peiran Su,Xinyue Zhang,Musaddeque Ahmed,Wei Chen,Moliang Chen,Sujun Chen,Mykhaylo Slobodyanyuk,Zhongpeng Xie,Jiansheng Guan,Wen Zhang,Aafaque Ahmad Khan,Shingo Sakashita,Ni Liu,Nhu-An Pham,Paul C. Boutros,Zunfu Ke,Michael F. Moran,Zongwei Cai,Chao Cheng,Jun Yu,Ming S. Tsao,Housheng H. He

DOI: https://doi.org/10.1158/2159-8290.27434102

2024-01-01

Abstract:Live cell imaging of EML4-overexpressing A549 cells in wound healing assay.
EP16.03-044 Genomic Evidence Depicting Clonal Evolution of Lung Adenosquamous Carcinoma

Y. Han,S. Lu,R. Zhao,Y. Xu,Y. Chen,C. Xiang,Q. Wu,S. Chen,J. Pang,Z. Shang,J. Zhao,H. Bao,Y. Shao

DOI: https://doi.org/10.1016/j.jtho.2022.07.1105

IF: 20.121

2022-01-01

Journal of Thoracic Oncology

Abstract:Adenosquamous carcinoma (ASC) is a rare subtype of non-small-cell lung cancer containing both adenocarcinoma (AC) and squamous cell carcinoma (SCC) components. However, the genomic background, tumor origins, and mechanisms of ASC are not fully understood.
Supplementary Figure S7 from the N6-methyladenosine Epitranscriptomic Landscape of Lung Adenocarcinoma

Shiyan Wang,Yong Zeng,Lin Zhu,Min Zhang,Lei Zhou,Weixiong Yang,Weishan Luo,Lina Wang,Yanming Liu,Helen Zhu,Xin Xu,Peiran Su,Xinyue Zhang,Musaddeque Ahmed,Wei Chen,Moliang Chen,Sujun Chen,Mykhaylo Slobodyanyuk,Zhongpeng Xie,Jiansheng Guan,Wen Zhang,Aafaque Ahmad Khan,Shingo Sakashita,Ni Liu,Nhu-An Pham,Paul C. Boutros,Zunfu Ke,Michael F. Moran,Zongwei Cai,Chao Cheng,Jun Yu,Ming S. Tsao,Housheng H. He

DOI: https://doi.org/10.1158/2159-8290.27434162

2024-01-01

Abstract:RNA-seq analysis of EML4-overexpressing, EML4-knockdown and control NSCLC cell samples.
Supplementary Figures 1-10 from CXCR2 Expression in Tumor Cells Is a Poor Prognostic Factor and Promotes Invasion and Metastasis in Lung Adenocarcinoma

Pierre Saintigny,Erminia Massarelli,Steven Lin,Young-Ho Ahn,Yulong Chen,Sangeeta Goswami,Baruch Erez,Michael S. O'Reilly,Diane Liu,J. Jack Lee,Li Zhang,Yuan Ping,Carmen Behrens,Luisa M. Solis Soto,John V. Heymach,Edward S. Kim,Roy S. Herbst,Scott M. Lippman,Ignacio I. Wistuba,Waun Ki Hong,Jonathan M. Kurie,Ja Seok Koo

DOI: https://doi.org/10.1158/0008-5472.22394124

2023-01-01

Abstract:<p>PDF file - 581K, Supplementary Figure 1: Distribution of cytoplasmic CXCR2 protein expression in 262 non-small cell lung cancer cell lines. Supplementary Figure 2: CXCR2 expression in tumor cells according to EGFR and KRAS mutation status. Supplementary Figure 3: Kaplan-Meier curves Supplementary Figure 4: Distribution of expression of CXCR2 and its ligand genes Supplementary Figure 5: CXCR2/CXCR2 ligands cluster is associated with a worse overall survival in patients with lung adenocarcinoma (N=442) Supplementary Figure 6: TTF-1 gene expression was more frequently lower in lung adenocarcinomas Supplementary Figure 7: The first two principal components were computed using expression of CXCR2 and its ligand genes Supplementary Figure 8: The first two principal components were computed using expression of CXCR2 and its ligand genes Supplementary Figure 9: Expression of (A) CXCL1, (B) CXCL2, (C) CXCL3, and (D) CXCL6 genes was negatively correlated with the level of their promoter methylation as indicated by average beta-value. Supplementary Figure 10: The effect of two doses of decitabine</p>
Supplementary Figure 5 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Guangcun Cheng,Xueqing Sun,Jinglong Wang,Gang Xiao,Xiumin Wang,Xuemei Fan,Lidong Zu,Mingang Hao,Qing Qu,Yan Mao,Yunjing Xue,Jianhua Wang

DOI: https://doi.org/10.1158/0008-5472.22401678

2023-01-01

Abstract:PDF file - 570K, LCN2 promotes lung metastasis in balb/c nude mice.
Supplementary Figure 2 from EphB3 Is Overexpressed in Non–Small-Cell Lung Cancer and Promotes Tumor Metastasis by Enhancing Cell Survival and Migration

Xiao-Dan Ji,Guo Li,Yu-Xiong Feng,Jiang-Sha Zhao,Jing-Jing Li,Zhi-Jian Sun,Shuo Shi,Yue-Zhen Deng,Jun-Feng Xu,Yin-Qiu Zhu,H. Phillip Koeffler,Xiang-Jun Tong,Dong Xie

DOI: https://doi.org/10.1158/0008-5472.22385832

2023-01-01

Abstract:Supplementary Figure 2 from EphB3 Is Overexpressed in Non–Small-Cell Lung Cancer and Promotes Tumor Metastasis by Enhancing Cell Survival and Migration
Supplemental Figure 2 from an Integrated Molecular Analysis of Lung Adenocarcinomas Identifies Potential Therapeutic Targets among TTF1-Negative Tumors, Including DNA Repair Proteins and Nrf2

Robert J.G. Cardnell,Carmen Behrens,Lixia Diao,YouHong Fan,Ximing Tang,Pan Tong,John D. Minna,Gordon B. Mills,John V. Heymach,Ignacio I. Wistuba,Jing Wang,Lauren A. Byers

DOI: https://doi.org/10.1158/1078-0432.22455642

2023-01-01

Abstract:Supplemental Figure 2. Unsupervised hierarchical clustering of mRNA in LUAD.
Supplementary Video S4 from the N6-methyladenosine Epitranscriptomic Landscape of Lung Adenocarcinoma

Shiyan Wang,Yong Zeng,Lin Zhu,Min Zhang,Lei Zhou,Weixiong Yang,Weishan Luo,Lina Wang,Yanming Liu,Helen Zhu,Xin Xu,Peiran Su,Xinyue Zhang,Musaddeque Ahmed,Wei Chen,Moliang Chen,Sujun Chen,Mykhaylo Slobodyanyuk,Zhongpeng Xie,Jiansheng Guan,Wen Zhang,Aafaque Ahmad Khan,Shingo Sakashita,Ni Liu,Nhu-An Pham,Paul C. Boutros,Zunfu Ke,Michael F. Moran,Zongwei Cai,Chao Cheng,Jun Yu,Ming S. Tsao,Housheng H. He

DOI: https://doi.org/10.1158/2159-8290.27434093

2024-01-01

Abstract:Live cell imaging of EML4-overexpressing H358 cells in wound healing assay.
Supplementary Figure 2 from LSECtin Expressed on Melanoma Cells Promotes Tumor Progression by Inhibiting Antitumor T-cell Responses

Feng Xu,Jing Liu,Di Liu,Biao Liu,Min Wang,Zhiyuan Hu,Xuemei Du,Li Tang,Fuchu He

DOI: https://doi.org/10.1158/0008-5472.22399947.v1

2023-01-01

Abstract:PDF file - 31KB, Supplementary Figure 2 Determination of concentration of IL-6 and IL-10 within tumor.
Supplementary Figure 1 from EphB3 Is Overexpressed in Non–Small-Cell Lung Cancer and Promotes Tumor Metastasis by Enhancing Cell Survival and Migration

Xiao-Dan Ji,Guo Li,Yu-Xiong Feng,Jiang-Sha Zhao,Jing-Jing Li,Zhi-Jian Sun,Shuo Shi,Yue-Zhen Deng,Jun-Feng Xu,Yin-Qiu Zhu,H. Phillip Koeffler,Xiang-Jun Tong,Dong Xie

DOI: https://doi.org/10.1158/0008-5472.22385835

2023-01-01

Abstract:Supplementary Figure 1 from EphB3 Is Overexpressed in Non–Small-Cell Lung Cancer and Promotes Tumor Metastasis by Enhancing Cell Survival and Migration
Supplementary Figure 2 from Integrin Α6<sup>high</sup> Cell Population Functions As an Initiator in Tumorigenesis and Relapse of Human Liposarcoma

Lu Wang,Lingxian Wang,Ying Gu,Yongqian Shu,Yan Shen,Qian Xu

DOI: https://doi.org/10.1158/1535-7163.22496901.v1

2023-01-01

Abstract:PDF file - 64K, Integrin a6 and CD13 co-express in multiple malignant cancer cell lines.
Supplemental Figure 3 from Epithelial–Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor–Mediated Apoptosis in Non–Small Cell Lung Cancer

Renata Ferrarotto,Ruchitha Goonatilake,Suk Young Yoo,Pan Tong,Uma Giri,Shaohua Peng,John D. Minna,Luc Girard,Yuehong Wang,Liguang Wang,Lerong Li,Lixia Diao,David H. Peng,Don L. Gibbons,Bonnie S. Glisson,John V. Heymach,Jing Wang,Lauren A. Byers,Faye M. Johnson

DOI: https://doi.org/10.1158/1078-0432.22458890.v1

2023-01-01

Abstract:Dose-response curves for NSCLC cell lines and treatments from Fig. 5 on a linear scale.

Supplementary Figure 2 from Api6/AIM/Spα/CD5L Overexpression in Alveolar Type II Epithelial Cells Induces Spontaneous Lung Adenocarcinoma

Data from Api6/AIM/Spα/CD5L Overexpression in Alveolar Type II Epithelial Cells Induces Spontaneous Lung Adenocarcinoma

Alveolar Type Ii Cells Possess The Capability Of Initiating Lung Tumor Development

Supplementary Tables 1-3 from Activation of the Signal Transducers and Activators of the Transcription 3 Pathway in Alveolar Epithelial Cells Induces Inflammation and Adenocarcinomas in Mouse Lung

Supplementary Figure 1 from Stomatin-like Protein 2 is Overexpressed in Cancer and Involved in Regulating Cell Growth and Cell Adhesion in Human Esophageal Squamous Cell Carcinoma

Supplementary Data from Identification of Active Bronchioalveolar Stem Cells as the Cell of Origin in Lung Adenocarcinoma

Supplementary Figure S5 from the N6-methyladenosine Epitranscriptomic Landscape of Lung Adenocarcinoma

Supplementary Figure S1 from Molecular Portraits of Epithelial, Mesenchymal, and Hybrid States in Lung Adenocarcinoma and Their Relevance to Survival

Supplementary Text from CXCR2 Expression in Tumor Cells Is a Poor Prognostic Factor and Promotes Invasion and Metastasis in Lung Adenocarcinoma

Supplementary Video S2 from the N6-methyladenosine Epitranscriptomic Landscape of Lung Adenocarcinoma

EP16.03-044 Genomic Evidence Depicting Clonal Evolution of Lung Adenosquamous Carcinoma

Supplementary Figure S7 from the N6-methyladenosine Epitranscriptomic Landscape of Lung Adenocarcinoma

Supplementary Figures 1-10 from CXCR2 Expression in Tumor Cells Is a Poor Prognostic Factor and Promotes Invasion and Metastasis in Lung Adenocarcinoma

Supplementary Figure 5 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 2 from EphB3 Is Overexpressed in Non–Small-Cell Lung Cancer and Promotes Tumor Metastasis by Enhancing Cell Survival and Migration

Supplemental Figure 2 from an Integrated Molecular Analysis of Lung Adenocarcinomas Identifies Potential Therapeutic Targets among TTF1-Negative Tumors, Including DNA Repair Proteins and Nrf2

Supplementary Video S4 from the N6-methyladenosine Epitranscriptomic Landscape of Lung Adenocarcinoma

Supplementary Figure 2 from LSECtin Expressed on Melanoma Cells Promotes Tumor Progression by Inhibiting Antitumor T-cell Responses

Supplementary Figure 1 from EphB3 Is Overexpressed in Non–Small-Cell Lung Cancer and Promotes Tumor Metastasis by Enhancing Cell Survival and Migration

Supplementary Figure 2 from Integrin Α6&lt;sup&gt;high&lt;/sup&gt; Cell Population Functions As an Initiator in Tumorigenesis and Relapse of Human Liposarcoma

Supplemental Figure 3 from Epithelial–Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor–Mediated Apoptosis in Non–Small Cell Lung Cancer

Supplementary Figure 2 from Integrin Α6<sup>high</sup> Cell Population Functions As an Initiator in Tumorigenesis and Relapse of Human Liposarcoma